Why anti-cancer drugs do not always live up to expectations

by | Apr 9, 2026 | Health

For more than a decade, a class of drugs called BET inhibitors has been tested in cancer trials with high expectations. The biology looked promising. Many cancers depend on oncogenes that “Bromo- and Extra-Terminal domain” (BET) proteins help activate, so blocking BET proteins should slow tumor growth.

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments